Literature DB >> 34888112

Reprogramming of Ovarian Granulosa Cells by YAP1 Leads to Development of High-Grade Cancer with Mesenchymal Lineage and Serous Features.

Xiangmin Lv1,2, Chunbo He2,3, Cong Huang1, Guohua Hua1,3, Xingcheng Chen4,5, Barbara K Timm6, Victoria M Maclin6, Abigail A Haggerty7, Shelly K Aust7, Denae M Golden7, Bhavana J Dave7, Yun-An Tseng5, Li Chen1,8, Hongbo Wang1, Peichao Chen1,9, David L Klinkebiel10, Adam R Karpf4, Jixin Dong4, Ronny I Drapkin11, Bo R Rueda1, John S Davis2,4, Cheng Wang1,2.   

Abstract

Understanding the cell-of-origin of ovarian high grade serous cancer (HGSC) is the prerequisite for efficient prevention and early diagnosis of this most lethal gynecological cancer. Recently, a mesenchymal type of ovarian HGSC with the poorest prognosis among ovarian cancers was identified by both TCGA and AOCS studies. The cell-of-origin of this subtype of ovarian cancer is unknown. While pursuing studies to understand the role of the Hippo pathway in ovarian granulosa cell physiology and pathology, we unexpectedly found that the Yes-associated protein 1 (YAP1), the major effector of the Hippo signaling pathway, induced dedifferentiation and reprogramming of the ovarian granulosa cells, a unique type of ovarian follicular cells with mesenchymal lineage and high plasticity, leading to the development of high grade ovarian cancer with serous features. Our research results unveil a potential cell-of-origin for a subtype of HGSC with mesenchymal features.

Entities:  

Keywords:  Mesenchymal type of high grade serous cancer; Ovarian granulosa cells; YAP1 oncogene; cell dedifferentiation; cell reprogramming; the Hippo pathway

Year:  2020        PMID: 34888112      PMCID: PMC8654108          DOI: 10.1016/j.scib.2020.03.040

Source DB:  PubMed          Journal:  Sci Bull (Beijing)        ISSN: 2095-9273            Impact factor:   20.577


  76 in total

1.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

Authors:  Ronghui Li; Jialiang Liang; Su Ni; Ting Zhou; Xiaobing Qing; Huapeng Li; Wenzhi He; Jiekai Chen; Feng Li; Qiang Zhuang; Baoming Qin; Jianyong Xu; Wen Li; Jiayin Yang; Yi Gan; Dajiang Qin; Shipeng Feng; Hong Song; Dongshan Yang; Biliang Zhang; Lingwen Zeng; Liangxue Lai; Miguel Angel Esteban; Duanqing Pei
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

Review 2.  The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development.

Authors:  Evan R Barry; Fernando D Camargo
Journal:  Curr Opin Cell Biol       Date:  2013-01-10       Impact factor: 8.382

3.  Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.

Authors:  Ie-Ming Shih; Li Chen; Chen C Wang; Jinghua Gu; Ben Davidson; Leslie Cope; Robert J Kurman; Jianhua Xuan; Tian-Li Wang
Journal:  Am J Obstet Gynecol       Date:  2010-10-20       Impact factor: 8.661

Review 4.  Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.

Authors:  Niloofar N Nik; Russell Vang; Ie-Ming Shih; Robert J Kurman
Journal:  Annu Rev Pathol       Date:  2013-08-05       Impact factor: 23.472

5.  Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification.

Authors:  Samira Musah; Paul J Wrighton; Yefim Zaltsman; Xiaofen Zhong; Stefan Zorn; Matthew B Parlato; Cheston Hsiao; Sean P Palecek; Qiang Chang; William L Murphy; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

Review 6.  Coming into focus: the nonovarian origins of ovarian cancer.

Authors:  L Dubeau; R Drapkin
Journal:  Ann Oncol       Date:  2013-11       Impact factor: 32.976

Review 7.  The hippo signaling pathway in development and cancer.

Authors:  Duojia Pan
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

8.  Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.

Authors:  Cheng Wang; Xiangmin Lv; Chao Jiang; Crystal M Cordes; Lan Fu; Subodh M Lele; John S Davis
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.

Authors:  Chunbo He; Dagan Mao; Guohua Hua; Xiangmin Lv; Xingcheng Chen; Peter C Angeletti; Jixin Dong; Steven W Remmenga; Kerry J Rodabaugh; Jin Zhou; Paul F Lambert; Peixin Yang; John S Davis; Cheng Wang
Journal:  EMBO Mol Med       Date:  2015-11       Impact factor: 12.137

10.  Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.

Authors:  B V V G Reddy; Kenneth D Irvine
Journal:  Dev Cell       Date:  2013-03-11       Impact factor: 12.270

View more
  2 in total

1.  Sex Differences in Pubertal Circadian and Ultradian Rhythmic Development Under Semi-naturalistic Conditions.

Authors:  Azure D Grant; Linda Wilbrecht; Lance J Kriegsfeld
Journal:  J Biol Rhythms       Date:  2022-05-03       Impact factor: 3.649

2.  Adolescent Development of Biological Rhythms in Female Rats: Estradiol Dependence and Effects of Combined Contraceptives.

Authors:  Azure D Grant; Linda Wilbrecht; Lance J Kriegsfeld
Journal:  Front Physiol       Date:  2021-11-05       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.